After Maggi, its now Dettol !

FDA cited quality issues with dettol soaps tested in India

det

Along with Dettol, 10 other medicines has failed the similar test

According to reports, a sample of Dettol soap another product from a multi-national brand owned by Reckitt Benckiser (RB) India, has failed laboratory test. Along with Dettol, 10 other medicines has also failed the similar test.

The Food and Drugs Administration (FDA), say some reports,  has called Dettol substandard. "The sample of Dettol soap bar wrapper was collected to measure its weight, which was supposed to be 125gm. But its actual weight in the test was 117.0470gms," said Mr RC Yadav, Agra drug inspector.

The FDA has planned to send notices to these different 11 companies because their product was found to be sub-standard. Meanwhile, after the UP FDA suspected Dettol soap for its lesser weight, Fast-Moving Consumer Goods (FMCG) firm, RB said it would do a thorough investigation and cooperate with other authorities.

According to the RB, the issue was not about the quality, as suggested in some reports, but about lesser weight. "To understand the alleged differences in the sample of the product weight, we would collaborate with the concerned authorities and do a thorough investigations," said a representative of the firm.

"Technically, all soaps lose moisture during the journey to retail outlets and hence we witness a drop in the weight," the spokesperson added.

The company further stressed that though media reports suggested a quality issue, the letter received from the FDA stated an issue with lesser weight and not in the quality.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology

Bwi-logo

Boehringer Ingelheim HCP Survey: Nearly 20% of newly diagnosed lung cancer

Thursday, 8 Dec 2016   |   Boehringer Ingelheim

Business Wire India Results from a new international survey of physicians revealed more patients with

Clinically meaningful data for oral nintedanib in mesothelioma presented

Thursday, 8 Dec 2016   |   Boehringer Ingelheim

Business Wire India Boehringer Ingelheim announced that the LUME-Meso Phase II trial in patients with

New governance at CellProthera

Wednesday, 7 Dec 2016   |   CellProthera

Business Wire India CellProthera, which offers the most advanced cell therapy for the regeneration of

BusinessWire India.com - Pharmaceutical

Bwi-logo

Boehringer Ingelheim HCP Survey: Nearly 20% of newly diagnosed lung cancer

Thursday, 8 Dec 2016   |   Boehringer Ingelheim

Business Wire India Results from a new international survey of physicians revealed more patients with

Clinically meaningful data for oral nintedanib in mesothelioma presented

Thursday, 8 Dec 2016   |   Boehringer Ingelheim

Business Wire India Boehringer Ingelheim announced that the LUME-Meso Phase II trial in patients with

New governance at CellProthera

Wednesday, 7 Dec 2016   |   CellProthera

Business Wire India CellProthera, which offers the most advanced cell therapy for the regeneration of

BusinessWire India.com - Medical Devices

Bwi-logo

BGS Global Hospital Performs Successful Liver Transplant to Treat Acute

Wednesday, 7 Dec 2016   |   BGS Global Hospitals

Business Wire India Karnataka’s largest liver transplant program clocks in 140 liver transplants

Worldwide Achievers Felicitated the Winners of International Healthcare

Monday, 5 Dec 2016   |   Worldwide Achievers Pvt. Ltd

Business Wire India Worldwide Achievers has initiated the International Healthcare Summit & Awards 2016 association with

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X